nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—CYP2A6—Methoxsalen—psoriasis	0.0856	0.13	CbGbCtD
Desipramine—CYP1A2—Clobetasol propionate—psoriasis	0.0622	0.0942	CbGbCtD
Desipramine—CYP2A6—Prednisolone—psoriasis	0.0416	0.063	CbGbCtD
Desipramine—CYP2B6—Cholecalciferol—psoriasis	0.0369	0.0559	CbGbCtD
Desipramine—CYP1A2—Methoxsalen—psoriasis	0.0327	0.0495	CbGbCtD
Desipramine—CYP2D6—Hydroxyurea—psoriasis	0.0294	0.0446	CbGbCtD
Desipramine—CYP2A6—Dexamethasone—psoriasis	0.0245	0.0371	CbGbCtD
Desipramine—CYP2C19—Cholecalciferol—psoriasis	0.0235	0.0355	CbGbCtD
Desipramine—CYP3A4—Calcitriol—psoriasis	0.022	0.0333	CbGbCtD
Desipramine—CYP2D6—Cholecalciferol—psoriasis	0.0178	0.027	CbGbCtD
Desipramine—CYP3A4—Methoxsalen—psoriasis	0.0171	0.0259	CbGbCtD
Desipramine—ABCB1—Mycophenolate mofetil—psoriasis	0.0164	0.0248	CbGbCtD
Desipramine—CYP2C19—Prednisone—psoriasis	0.0163	0.0246	CbGbCtD
Desipramine—CYP2E1—Dexamethasone—psoriasis	0.0162	0.0245	CbGbCtD
Desipramine—CYP2B6—Dexamethasone—psoriasis	0.016	0.0242	CbGbCtD
Desipramine—CYP2C19—Cyclosporine—psoriasis	0.0154	0.0233	CbGbCtD
Desipramine—ABCB1—Betamethasone—psoriasis	0.0141	0.0213	CbGbCtD
Desipramine—ABCB1—Prednisolone—psoriasis	0.0139	0.021	CbGbCtD
Desipramine—ABCB1—Hydrocortisone—psoriasis	0.0132	0.0199	CbGbCtD
Desipramine—ABCB1—Prednisone—psoriasis	0.0131	0.0199	CbGbCtD
Desipramine—ABCB1—Cyclosporine—psoriasis	0.0124	0.0188	CbGbCtD
Desipramine—CYP2D6—Cyclosporine—psoriasis	0.0117	0.0177	CbGbCtD
Desipramine—CYP3A4—Cholecalciferol—psoriasis	0.0113	0.0172	CbGbCtD
Desipramine—CYP2C19—Dexamethasone—psoriasis	0.0102	0.0154	CbGbCtD
Desipramine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00983	0.0149	CbGbCtD
Desipramine—CYP3A4—Triamcinolone—psoriasis	0.00983	0.0149	CbGbCtD
Desipramine—CYP3A4—Betamethasone—psoriasis	0.00844	0.0128	CbGbCtD
Desipramine—CYP3A4—Prednisolone—psoriasis	0.00832	0.0126	CbGbCtD
Desipramine—ABCB1—Dexamethasone—psoriasis	0.00819	0.0124	CbGbCtD
Desipramine—CYP3A4—Hydrocortisone—psoriasis	0.00789	0.0119	CbGbCtD
Desipramine—CYP3A4—Prednisone—psoriasis	0.00786	0.0119	CbGbCtD
Desipramine—CYP2D6—Dexamethasone—psoriasis	0.00772	0.0117	CbGbCtD
Desipramine—CYP3A4—Cyclosporine—psoriasis	0.00745	0.0113	CbGbCtD
Desipramine—ABCB1—Methotrexate—psoriasis	0.00658	0.00996	CbGbCtD
Desipramine—CYP3A4—Dexamethasone—psoriasis	0.00491	0.00743	CbGbCtD
Desipramine—Arrhythmia—Betamethasone—psoriasis	0.000227	0.000905	CcSEcCtD
Desipramine—Anorexia—Cyclosporine—psoriasis	0.000227	0.000903	CcSEcCtD
Desipramine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000226	0.000902	CcSEcCtD
Desipramine—Ill-defined disorder—Triamcinolone—psoriasis	0.000226	0.000902	CcSEcCtD
Desipramine—Alopecia—Betamethasone—psoriasis	0.000224	0.000895	CcSEcCtD
Desipramine—Alopecia—Dexamethasone—psoriasis	0.000224	0.000895	CcSEcCtD
Desipramine—Convulsion—Hydrocortisone—psoriasis	0.000224	0.000894	CcSEcCtD
Desipramine—Hypertension—Hydrocortisone—psoriasis	0.000223	0.000891	CcSEcCtD
Desipramine—Vomiting—Hydroxyurea—psoriasis	0.000223	0.000889	CcSEcCtD
Desipramine—Discomfort—Prednisolone—psoriasis	0.000223	0.000889	CcSEcCtD
Desipramine—Rash—Hydroxyurea—psoriasis	0.000221	0.000882	CcSEcCtD
Desipramine—Anorexia—Mycophenolate mofetil—psoriasis	0.000221	0.000881	CcSEcCtD
Desipramine—Dermatitis—Hydroxyurea—psoriasis	0.000221	0.000881	CcSEcCtD
Desipramine—Hallucination—Prednisone—psoriasis	0.00022	0.000878	CcSEcCtD
Desipramine—Malaise—Triamcinolone—psoriasis	0.00022	0.000876	CcSEcCtD
Desipramine—Headache—Hydroxyurea—psoriasis	0.00022	0.000876	CcSEcCtD
Desipramine—Anxiety—Hydrocortisone—psoriasis	0.00022	0.000876	CcSEcCtD
Desipramine—Discomfort—Hydrocortisone—psoriasis	0.000218	0.000868	CcSEcCtD
Desipramine—Hypotension—Mycophenolate mofetil—psoriasis	0.000217	0.000864	CcSEcCtD
Desipramine—Oedema—Prednisolone—psoriasis	0.000216	0.000862	CcSEcCtD
Desipramine—Insomnia—Cyclosporine—psoriasis	0.000215	0.000857	CcSEcCtD
Desipramine—Paraesthesia—Cyclosporine—psoriasis	0.000213	0.000851	CcSEcCtD
Desipramine—Erectile dysfunction—Methotrexate—psoriasis	0.000213	0.000848	CcSEcCtD
Desipramine—Somnolence—Cyclosporine—psoriasis	0.000211	0.000842	CcSEcCtD
Desipramine—Oedema—Hydrocortisone—psoriasis	0.000211	0.000842	CcSEcCtD
Desipramine—Convulsion—Triamcinolone—psoriasis	0.000211	0.000842	CcSEcCtD
Desipramine—Tachycardia—Prednisolone—psoriasis	0.000211	0.000842	CcSEcCtD
Desipramine—Asthenia—Mycophenolic acid—psoriasis	0.000211	0.00084	CcSEcCtD
Desipramine—Hypertension—Triamcinolone—psoriasis	0.00021	0.000839	CcSEcCtD
Desipramine—Insomnia—Mycophenolate mofetil—psoriasis	0.00021	0.000836	CcSEcCtD
Desipramine—Dyspepsia—Cyclosporine—psoriasis	0.000209	0.000834	CcSEcCtD
Desipramine—Nausea—Hydroxyurea—psoriasis	0.000208	0.000831	CcSEcCtD
Desipramine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000208	0.00083	CcSEcCtD
Desipramine—Pruritus—Mycophenolic acid—psoriasis	0.000208	0.000829	CcSEcCtD
Desipramine—Decreased appetite—Cyclosporine—psoriasis	0.000207	0.000824	CcSEcCtD
Desipramine—Tachycardia—Hydrocortisone—psoriasis	0.000206	0.000822	CcSEcCtD
Desipramine—Somnolence—Mycophenolate mofetil—psoriasis	0.000206	0.000822	CcSEcCtD
Desipramine—Drowsiness—Methotrexate—psoriasis	0.000206	0.000821	CcSEcCtD
Desipramine—Depression—Methotrexate—psoriasis	0.000205	0.000819	CcSEcCtD
Desipramine—Flushing—Prednisone—psoriasis	0.000205	0.000819	CcSEcCtD
Desipramine—Ill-defined disorder—Betamethasone—psoriasis	0.000205	0.000818	CcSEcCtD
Desipramine—Ill-defined disorder—Dexamethasone—psoriasis	0.000205	0.000818	CcSEcCtD
Desipramine—Discomfort—Triamcinolone—psoriasis	0.000205	0.000817	CcSEcCtD
Desipramine—Fatigue—Cyclosporine—psoriasis	0.000205	0.000817	CcSEcCtD
Desipramine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000204	0.000814	CcSEcCtD
Desipramine—Constipation—Cyclosporine—psoriasis	0.000203	0.00081	CcSEcCtD
Desipramine—Dry mouth—Triamcinolone—psoriasis	0.000203	0.000809	CcSEcCtD
Desipramine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000202	0.000804	CcSEcCtD
Desipramine—Anorexia—Hydrocortisone—psoriasis	0.000201	0.000803	CcSEcCtD
Desipramine—Diarrhoea—Mycophenolic acid—psoriasis	0.000201	0.000801	CcSEcCtD
Desipramine—Stomatitis—Methotrexate—psoriasis	0.000201	0.0008	CcSEcCtD
Desipramine—Malaise—Betamethasone—psoriasis	0.000199	0.000795	CcSEcCtD
Desipramine—Malaise—Dexamethasone—psoriasis	0.000199	0.000795	CcSEcCtD
Desipramine—Oedema—Triamcinolone—psoriasis	0.000199	0.000793	CcSEcCtD
Desipramine—Constipation—Mycophenolate mofetil—psoriasis	0.000198	0.000791	CcSEcCtD
Desipramine—Arrhythmia—Prednisone—psoriasis	0.000198	0.000788	CcSEcCtD
Desipramine—Hypotension—Hydrocortisone—psoriasis	0.000197	0.000787	CcSEcCtD
Desipramine—Feeling abnormal—Cyclosporine—psoriasis	0.000196	0.000781	CcSEcCtD
Desipramine—Insomnia—Prednisolone—psoriasis	0.000196	0.00078	CcSEcCtD
Desipramine—Alopecia—Prednisone—psoriasis	0.000195	0.000779	CcSEcCtD
Desipramine—Dizziness—Mycophenolic acid—psoriasis	0.000194	0.000775	CcSEcCtD
Desipramine—Paraesthesia—Prednisolone—psoriasis	0.000194	0.000774	CcSEcCtD
Desipramine—Tachycardia—Triamcinolone—psoriasis	0.000194	0.000774	CcSEcCtD
Desipramine—Agranulocytosis—Methotrexate—psoriasis	0.000192	0.000766	CcSEcCtD
Desipramine—Convulsion—Dexamethasone—psoriasis	0.000192	0.000764	CcSEcCtD
Desipramine—Convulsion—Betamethasone—psoriasis	0.000192	0.000764	CcSEcCtD
Desipramine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000191	0.000762	CcSEcCtD
Desipramine—Insomnia—Hydrocortisone—psoriasis	0.000191	0.000762	CcSEcCtD
Desipramine—Hypertension—Betamethasone—psoriasis	0.000191	0.000761	CcSEcCtD
Desipramine—Hypertension—Dexamethasone—psoriasis	0.000191	0.000761	CcSEcCtD
Desipramine—Paraesthesia—Hydrocortisone—psoriasis	0.00019	0.000756	CcSEcCtD
Desipramine—Urticaria—Cyclosporine—psoriasis	0.000189	0.000753	CcSEcCtD
Desipramine—Abdominal pain—Cyclosporine—psoriasis	0.000188	0.000749	CcSEcCtD
Desipramine—Body temperature increased—Cyclosporine—psoriasis	0.000188	0.000749	CcSEcCtD
Desipramine—Anxiety—Dexamethasone—psoriasis	0.000188	0.000748	CcSEcCtD
Desipramine—Anxiety—Betamethasone—psoriasis	0.000188	0.000748	CcSEcCtD
Desipramine—Vomiting—Mycophenolic acid—psoriasis	0.000187	0.000745	CcSEcCtD
Desipramine—Discomfort—Dexamethasone—psoriasis	0.000186	0.000742	CcSEcCtD
Desipramine—Discomfort—Betamethasone—psoriasis	0.000186	0.000742	CcSEcCtD
Desipramine—Dyspepsia—Hydrocortisone—psoriasis	0.000186	0.000741	CcSEcCtD
Desipramine—Rash—Mycophenolic acid—psoriasis	0.000185	0.000739	CcSEcCtD
Desipramine—Dermatitis—Mycophenolic acid—psoriasis	0.000185	0.000738	CcSEcCtD
Desipramine—Hepatitis—Methotrexate—psoriasis	0.000185	0.000737	CcSEcCtD
Desipramine—Urticaria—Mycophenolate mofetil—psoriasis	0.000184	0.000734	CcSEcCtD
Desipramine—Headache—Mycophenolic acid—psoriasis	0.000184	0.000734	CcSEcCtD
Desipramine—Decreased appetite—Hydrocortisone—psoriasis	0.000184	0.000732	CcSEcCtD
Desipramine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000183	0.000731	CcSEcCtD
Desipramine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000183	0.000731	CcSEcCtD
Desipramine—Fatigue—Hydrocortisone—psoriasis	0.000182	0.000726	CcSEcCtD
Desipramine—Vision blurred—Prednisone—psoriasis	0.000181	0.000724	CcSEcCtD
Desipramine—Oedema—Dexamethasone—psoriasis	0.00018	0.00072	CcSEcCtD
Desipramine—Oedema—Betamethasone—psoriasis	0.00018	0.00072	CcSEcCtD
Desipramine—Insomnia—Triamcinolone—psoriasis	0.00018	0.000717	CcSEcCtD
Desipramine—Ill-defined disorder—Prednisone—psoriasis	0.000179	0.000712	CcSEcCtD
Desipramine—Paraesthesia—Triamcinolone—psoriasis	0.000179	0.000712	CcSEcCtD
Desipramine—Feeling abnormal—Prednisolone—psoriasis	0.000178	0.000711	CcSEcCtD
Desipramine—Agitation—Prednisone—psoriasis	0.000177	0.000706	CcSEcCtD
Desipramine—Thrombocytopenia—Betamethasone—psoriasis	0.000177	0.000705	CcSEcCtD
Desipramine—Thrombocytopenia—Dexamethasone—psoriasis	0.000177	0.000705	CcSEcCtD
Desipramine—Tachycardia—Betamethasone—psoriasis	0.000176	0.000702	CcSEcCtD
Desipramine—Tachycardia—Dexamethasone—psoriasis	0.000176	0.000702	CcSEcCtD
Desipramine—Dyspepsia—Triamcinolone—psoriasis	0.000175	0.000698	CcSEcCtD
Desipramine—Nausea—Mycophenolic acid—psoriasis	0.000174	0.000696	CcSEcCtD
Desipramine—Feeling abnormal—Hydrocortisone—psoriasis	0.000174	0.000694	CcSEcCtD
Desipramine—Malaise—Prednisone—psoriasis	0.000174	0.000692	CcSEcCtD
Desipramine—Tinnitus—Methotrexate—psoriasis	0.000172	0.000687	CcSEcCtD
Desipramine—Anorexia—Betamethasone—psoriasis	0.000172	0.000686	CcSEcCtD
Desipramine—Anorexia—Dexamethasone—psoriasis	0.000172	0.000686	CcSEcCtD
Desipramine—Urticaria—Prednisolone—psoriasis	0.000172	0.000685	CcSEcCtD
Desipramine—Fatigue—Triamcinolone—psoriasis	0.000171	0.000684	CcSEcCtD
Desipramine—Asthenia—Cyclosporine—psoriasis	0.000171	0.00068	CcSEcCtD
Desipramine—Hypotension—Dexamethasone—psoriasis	0.000169	0.000672	CcSEcCtD
Desipramine—Hypotension—Betamethasone—psoriasis	0.000169	0.000672	CcSEcCtD
Desipramine—Pruritus—Cyclosporine—psoriasis	0.000168	0.00067	CcSEcCtD
Desipramine—Urticaria—Hydrocortisone—psoriasis	0.000168	0.000669	CcSEcCtD
Desipramine—Abdominal pain—Hydrocortisone—psoriasis	0.000167	0.000666	CcSEcCtD
Desipramine—Body temperature increased—Hydrocortisone—psoriasis	0.000167	0.000666	CcSEcCtD
Desipramine—Convulsion—Prednisone—psoriasis	0.000167	0.000665	CcSEcCtD
Desipramine—Asthenia—Mycophenolate mofetil—psoriasis	0.000166	0.000663	CcSEcCtD
Desipramine—Hypertension—Prednisone—psoriasis	0.000166	0.000663	CcSEcCtD
Desipramine—Pruritus—Mycophenolate mofetil—psoriasis	0.000164	0.000654	CcSEcCtD
Desipramine—Feeling abnormal—Triamcinolone—psoriasis	0.000164	0.000654	CcSEcCtD
Desipramine—Anxiety—Prednisone—psoriasis	0.000163	0.000651	CcSEcCtD
Desipramine—Alopecia—Methotrexate—psoriasis	0.000163	0.000651	CcSEcCtD
Desipramine—Insomnia—Betamethasone—psoriasis	0.000163	0.000651	CcSEcCtD
Desipramine—Insomnia—Dexamethasone—psoriasis	0.000163	0.000651	CcSEcCtD
Desipramine—Diarrhoea—Cyclosporine—psoriasis	0.000163	0.000648	CcSEcCtD
Desipramine—Paraesthesia—Dexamethasone—psoriasis	0.000162	0.000646	CcSEcCtD
Desipramine—Paraesthesia—Betamethasone—psoriasis	0.000162	0.000646	CcSEcCtD
Desipramine—Discomfort—Prednisone—psoriasis	0.000162	0.000646	CcSEcCtD
Desipramine—Dyspepsia—Betamethasone—psoriasis	0.000159	0.000633	CcSEcCtD
Desipramine—Dyspepsia—Dexamethasone—psoriasis	0.000159	0.000633	CcSEcCtD
Desipramine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000159	0.000633	CcSEcCtD
Desipramine—Urticaria—Triamcinolone—psoriasis	0.000158	0.00063	CcSEcCtD
Desipramine—Dysgeusia—Methotrexate—psoriasis	0.000158	0.000628	CcSEcCtD
Desipramine—Body temperature increased—Triamcinolone—psoriasis	0.000157	0.000627	CcSEcCtD
Desipramine—Dizziness—Cyclosporine—psoriasis	0.000157	0.000627	CcSEcCtD
Desipramine—Oedema—Prednisone—psoriasis	0.000157	0.000627	CcSEcCtD
Desipramine—Decreased appetite—Betamethasone—psoriasis	0.000157	0.000626	CcSEcCtD
Desipramine—Decreased appetite—Dexamethasone—psoriasis	0.000157	0.000626	CcSEcCtD
Desipramine—Fatigue—Betamethasone—psoriasis	0.000156	0.00062	CcSEcCtD
Desipramine—Fatigue—Dexamethasone—psoriasis	0.000156	0.00062	CcSEcCtD
Desipramine—Tachycardia—Prednisone—psoriasis	0.000153	0.000612	CcSEcCtD
Desipramine—Dizziness—Mycophenolate mofetil—psoriasis	0.000153	0.000611	CcSEcCtD
Desipramine—Vision blurred—Methotrexate—psoriasis	0.000152	0.000605	CcSEcCtD
Desipramine—Asthenia—Hydrocortisone—psoriasis	0.000152	0.000604	CcSEcCtD
Desipramine—Vomiting—Cyclosporine—psoriasis	0.000151	0.000603	CcSEcCtD
Desipramine—Rash—Cyclosporine—psoriasis	0.00015	0.000598	CcSEcCtD
Desipramine—Anorexia—Prednisone—psoriasis	0.00015	0.000597	CcSEcCtD
Desipramine—Dermatitis—Cyclosporine—psoriasis	0.00015	0.000597	CcSEcCtD
Desipramine—Pruritus—Hydrocortisone—psoriasis	0.000149	0.000596	CcSEcCtD
Desipramine—Ill-defined disorder—Methotrexate—psoriasis	0.000149	0.000595	CcSEcCtD
Desipramine—Headache—Cyclosporine—psoriasis	0.000149	0.000594	CcSEcCtD
Desipramine—Feeling abnormal—Dexamethasone—psoriasis	0.000149	0.000593	CcSEcCtD
Desipramine—Feeling abnormal—Betamethasone—psoriasis	0.000149	0.000593	CcSEcCtD
Desipramine—Vomiting—Mycophenolate mofetil—psoriasis	0.000147	0.000588	CcSEcCtD
Desipramine—Rash—Mycophenolate mofetil—psoriasis	0.000146	0.000583	CcSEcCtD
Desipramine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000146	0.000582	CcSEcCtD
Desipramine—Headache—Mycophenolate mofetil—psoriasis	0.000145	0.000579	CcSEcCtD
Desipramine—Malaise—Methotrexate—psoriasis	0.000145	0.000579	CcSEcCtD
Desipramine—Diarrhoea—Hydrocortisone—psoriasis	0.000145	0.000576	CcSEcCtD
Desipramine—Urticaria—Dexamethasone—psoriasis	0.000143	0.000572	CcSEcCtD
Desipramine—Urticaria—Betamethasone—psoriasis	0.000143	0.000572	CcSEcCtD
Desipramine—Dizziness—Prednisolone—psoriasis	0.000143	0.00057	CcSEcCtD
Desipramine—Asthenia—Triamcinolone—psoriasis	0.000143	0.000569	CcSEcCtD
Desipramine—Abdominal pain—Dexamethasone—psoriasis	0.000143	0.000569	CcSEcCtD
Desipramine—Abdominal pain—Betamethasone—psoriasis	0.000143	0.000569	CcSEcCtD
Desipramine—Body temperature increased—Betamethasone—psoriasis	0.000143	0.000569	CcSEcCtD
Desipramine—Body temperature increased—Dexamethasone—psoriasis	0.000143	0.000569	CcSEcCtD
Desipramine—Insomnia—Prednisone—psoriasis	0.000142	0.000567	CcSEcCtD
Desipramine—Nausea—Cyclosporine—psoriasis	0.000141	0.000563	CcSEcCtD
Desipramine—Paraesthesia—Prednisone—psoriasis	0.000141	0.000563	CcSEcCtD
Desipramine—Pruritus—Triamcinolone—psoriasis	0.000141	0.000561	CcSEcCtD
Desipramine—Dizziness—Hydrocortisone—psoriasis	0.00014	0.000557	CcSEcCtD
Desipramine—Convulsion—Methotrexate—psoriasis	0.000139	0.000556	CcSEcCtD
Desipramine—Dyspepsia—Prednisone—psoriasis	0.000138	0.000552	CcSEcCtD
Desipramine—Nausea—Mycophenolate mofetil—psoriasis	0.000138	0.000549	CcSEcCtD
Desipramine—Decreased appetite—Prednisone—psoriasis	0.000137	0.000545	CcSEcCtD
Desipramine—Rash—Prednisolone—psoriasis	0.000136	0.000544	CcSEcCtD
Desipramine—Dermatitis—Prednisolone—psoriasis	0.000136	0.000543	CcSEcCtD
Desipramine—Fatigue—Prednisone—psoriasis	0.000135	0.00054	CcSEcCtD
Desipramine—Headache—Prednisolone—psoriasis	0.000135	0.00054	CcSEcCtD
Desipramine—Discomfort—Methotrexate—psoriasis	0.000135	0.00054	CcSEcCtD
Desipramine—Constipation—Prednisone—psoriasis	0.000134	0.000536	CcSEcCtD
Desipramine—Vomiting—Hydrocortisone—psoriasis	0.000134	0.000535	CcSEcCtD
Desipramine—Rash—Hydrocortisone—psoriasis	0.000133	0.000531	CcSEcCtD
Desipramine—Dermatitis—Hydrocortisone—psoriasis	0.000133	0.000531	CcSEcCtD
Desipramine—Confusional state—Methotrexate—psoriasis	0.000132	0.000528	CcSEcCtD
Desipramine—Headache—Hydrocortisone—psoriasis	0.000132	0.000528	CcSEcCtD
Desipramine—Dizziness—Triamcinolone—psoriasis	0.000132	0.000524	CcSEcCtD
Desipramine—Feeling abnormal—Prednisone—psoriasis	0.000129	0.000516	CcSEcCtD
Desipramine—Asthenia—Dexamethasone—psoriasis	0.000129	0.000516	CcSEcCtD
Desipramine—Asthenia—Betamethasone—psoriasis	0.000129	0.000516	CcSEcCtD
Desipramine—Thrombocytopenia—Methotrexate—psoriasis	0.000129	0.000513	CcSEcCtD
Desipramine—Nausea—Prednisolone—psoriasis	0.000128	0.000512	CcSEcCtD
Desipramine—Pruritus—Dexamethasone—psoriasis	0.000128	0.000509	CcSEcCtD
Desipramine—Pruritus—Betamethasone—psoriasis	0.000128	0.000509	CcSEcCtD
Desipramine—Vomiting—Triamcinolone—psoriasis	0.000126	0.000504	CcSEcCtD
Desipramine—Nausea—Hydrocortisone—psoriasis	0.000125	0.0005	CcSEcCtD
Desipramine—Rash—Triamcinolone—psoriasis	0.000125	0.0005	CcSEcCtD
Desipramine—Dermatitis—Triamcinolone—psoriasis	0.000125	0.0005	CcSEcCtD
Desipramine—Anorexia—Methotrexate—psoriasis	0.000125	0.000499	CcSEcCtD
Desipramine—Urticaria—Prednisone—psoriasis	0.000125	0.000498	CcSEcCtD
Desipramine—Headache—Triamcinolone—psoriasis	0.000125	0.000497	CcSEcCtD
Desipramine—Body temperature increased—Prednisone—psoriasis	0.000124	0.000495	CcSEcCtD
Desipramine—Abdominal pain—Prednisone—psoriasis	0.000124	0.000495	CcSEcCtD
Desipramine—Diarrhoea—Dexamethasone—psoriasis	0.000123	0.000492	CcSEcCtD
Desipramine—Diarrhoea—Betamethasone—psoriasis	0.000123	0.000492	CcSEcCtD
Desipramine—Hypotension—Methotrexate—psoriasis	0.000123	0.000489	CcSEcCtD
Desipramine—Dizziness—Betamethasone—psoriasis	0.000119	0.000476	CcSEcCtD
Desipramine—Dizziness—Dexamethasone—psoriasis	0.000119	0.000476	CcSEcCtD
Desipramine—Insomnia—Methotrexate—psoriasis	0.000119	0.000474	CcSEcCtD
Desipramine—Nausea—Triamcinolone—psoriasis	0.000118	0.000471	CcSEcCtD
Desipramine—Paraesthesia—Methotrexate—psoriasis	0.000118	0.00047	CcSEcCtD
Desipramine—Somnolence—Methotrexate—psoriasis	0.000117	0.000466	CcSEcCtD
Desipramine—Dyspepsia—Methotrexate—psoriasis	0.000116	0.000461	CcSEcCtD
Desipramine—Vomiting—Betamethasone—psoriasis	0.000115	0.000458	CcSEcCtD
Desipramine—Vomiting—Dexamethasone—psoriasis	0.000115	0.000458	CcSEcCtD
Desipramine—Decreased appetite—Methotrexate—psoriasis	0.000114	0.000455	CcSEcCtD
Desipramine—Rash—Dexamethasone—psoriasis	0.000114	0.000454	CcSEcCtD
Desipramine—Rash—Betamethasone—psoriasis	0.000114	0.000454	CcSEcCtD
Desipramine—Dermatitis—Dexamethasone—psoriasis	0.000114	0.000453	CcSEcCtD
Desipramine—Dermatitis—Betamethasone—psoriasis	0.000114	0.000453	CcSEcCtD
Desipramine—Fatigue—Methotrexate—psoriasis	0.000113	0.000452	CcSEcCtD
Desipramine—Headache—Betamethasone—psoriasis	0.000113	0.000451	CcSEcCtD
Desipramine—Headache—Dexamethasone—psoriasis	0.000113	0.000451	CcSEcCtD
Desipramine—Asthenia—Prednisone—psoriasis	0.000113	0.00045	CcSEcCtD
Desipramine—Pruritus—Prednisone—psoriasis	0.000111	0.000443	CcSEcCtD
Desipramine—Feeling abnormal—Methotrexate—psoriasis	0.000108	0.000432	CcSEcCtD
Desipramine—Diarrhoea—Prednisone—psoriasis	0.000108	0.000429	CcSEcCtD
Desipramine—Nausea—Betamethasone—psoriasis	0.000107	0.000427	CcSEcCtD
Desipramine—Nausea—Dexamethasone—psoriasis	0.000107	0.000427	CcSEcCtD
Desipramine—Urticaria—Methotrexate—psoriasis	0.000104	0.000416	CcSEcCtD
Desipramine—Dizziness—Prednisone—psoriasis	0.000104	0.000414	CcSEcCtD
Desipramine—Body temperature increased—Methotrexate—psoriasis	0.000104	0.000414	CcSEcCtD
Desipramine—Abdominal pain—Methotrexate—psoriasis	0.000104	0.000414	CcSEcCtD
Desipramine—Vomiting—Prednisone—psoriasis	9.99e-05	0.000398	CcSEcCtD
Desipramine—Rash—Prednisone—psoriasis	9.91e-05	0.000395	CcSEcCtD
Desipramine—Dermatitis—Prednisone—psoriasis	9.9e-05	0.000395	CcSEcCtD
Desipramine—Headache—Prednisone—psoriasis	9.84e-05	0.000393	CcSEcCtD
Desipramine—Asthenia—Methotrexate—psoriasis	9.42e-05	0.000376	CcSEcCtD
Desipramine—Nausea—Prednisone—psoriasis	9.33e-05	0.000372	CcSEcCtD
Desipramine—Pruritus—Methotrexate—psoriasis	9.29e-05	0.000371	CcSEcCtD
Desipramine—Diarrhoea—Methotrexate—psoriasis	8.99e-05	0.000358	CcSEcCtD
Desipramine—Dizziness—Methotrexate—psoriasis	8.68e-05	0.000346	CcSEcCtD
Desipramine—Vomiting—Methotrexate—psoriasis	8.35e-05	0.000333	CcSEcCtD
Desipramine—Rash—Methotrexate—psoriasis	8.28e-05	0.00033	CcSEcCtD
Desipramine—Dermatitis—Methotrexate—psoriasis	8.27e-05	0.00033	CcSEcCtD
Desipramine—Headache—Methotrexate—psoriasis	8.23e-05	0.000328	CcSEcCtD
Desipramine—Nausea—Methotrexate—psoriasis	7.8e-05	0.000311	CcSEcCtD
Desipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.06e-05	0.000233	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.06e-05	0.000233	CbGpPWpGaD
Desipramine—CHRM1—GPCR ligand binding—CXCL8—psoriasis	2.06e-05	0.000233	CbGpPWpGaD
Desipramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.06e-05	0.000233	CbGpPWpGaD
Desipramine—CHRM3—GPCR ligand binding—CXCL8—psoriasis	2.06e-05	0.000232	CbGpPWpGaD
Desipramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.05e-05	0.000232	CbGpPWpGaD
Desipramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.05e-05	0.000231	CbGpPWpGaD
Desipramine—CHRM2—GPCR ligand binding—CXCL8—psoriasis	2.04e-05	0.00023	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—CARM1—psoriasis	2.02e-05	0.000228	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—CARM1—psoriasis	1.98e-05	0.000223	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—APOE—psoriasis	1.96e-05	0.000222	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—SOCS1—psoriasis	1.89e-05	0.000214	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.88e-05	0.000212	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—SOCS1—psoriasis	1.81e-05	0.000204	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—PPARG—psoriasis	1.81e-05	0.000204	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—TYK2—psoriasis	1.8e-05	0.000204	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.77e-05	0.0002	CbGpPWpGaD
Desipramine—CHRM4—GPCR downstream signaling—CXCL8—psoriasis	1.73e-05	0.000195	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—TYK2—psoriasis	1.73e-05	0.000195	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—PPARG—psoriasis	1.71e-05	0.000193	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—CAT—psoriasis	1.68e-05	0.000189	CbGpPWpGaD
Desipramine—CHRM5—GPCR downstream signaling—CXCL8—psoriasis	1.65e-05	0.000187	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.64e-05	0.000185	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—CXCL8—psoriasis	1.57e-05	0.000177	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—CAT—psoriasis	1.56e-05	0.000176	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.56e-05	0.000176	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—SOCS1—psoriasis	1.55e-05	0.000175	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—CAT—psoriasis	1.54e-05	0.000174	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CARM1—psoriasis	1.53e-05	0.000172	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—SOCS1—psoriasis	1.52e-05	0.000171	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—CXCL8—psoriasis	1.5e-05	0.00017	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CARM1—psoriasis	1.49e-05	0.000168	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—SOCS1—psoriasis	1.48e-05	0.000168	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—TYK2—psoriasis	1.48e-05	0.000167	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—SOCS1—psoriasis	1.48e-05	0.000167	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—TYK2—psoriasis	1.45e-05	0.000163	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—CAT—psoriasis	1.44e-05	0.000163	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.43e-05	0.000161	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—CXCL8—psoriasis	1.42e-05	0.00016	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—TYK2—psoriasis	1.41e-05	0.00016	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—TYK2—psoriasis	1.41e-05	0.000159	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CARM1—psoriasis	1.4e-05	0.000158	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—LEP—psoriasis	1.39e-05	0.000158	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—APOE—psoriasis	1.39e-05	0.000158	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—CXCL8—psoriasis	1.39e-05	0.000157	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	1.36e-05	0.000153	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	1.35e-05	0.000152	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—LEP—psoriasis	1.34e-05	0.000151	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—APOE—psoriasis	1.34e-05	0.000151	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—APOE—psoriasis	1.3e-05	0.000147	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SOCS1—psoriasis	1.3e-05	0.000147	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—NFKBIA—psoriasis	1.3e-05	0.000147	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—CXCL8—psoriasis	1.29e-05	0.000145	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SOCS1—psoriasis	1.28e-05	0.000145	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SOCS1—psoriasis	1.28e-05	0.000144	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.28e-05	0.000144	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SOCS1—psoriasis	1.27e-05	0.000144	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SOCS1—psoriasis	1.27e-05	0.000144	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—CXCL8—psoriasis	1.26e-05	0.000142	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SOCS1—psoriasis	1.26e-05	0.000142	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—NFKBIA—psoriasis	1.24e-05	0.000141	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—TYK2—psoriasis	1.24e-05	0.00014	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—CAT—psoriasis	1.24e-05	0.00014	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—CXCL8—psoriasis	1.23e-05	0.000139	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—CXCL8—psoriasis	1.22e-05	0.000138	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—TYK2—psoriasis	1.22e-05	0.000138	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—TYK2—psoriasis	1.22e-05	0.000138	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—CAT—psoriasis	1.22e-05	0.000137	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—TYK2—psoriasis	1.22e-05	0.000137	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—APOE—psoriasis	1.21e-05	0.000137	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—TYK2—psoriasis	1.21e-05	0.000137	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—TYK2—psoriasis	1.2e-05	0.000136	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—APOE—psoriasis	1.2e-05	0.000135	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.19e-05	0.000134	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CARM1—psoriasis	1.19e-05	0.000134	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	1.17e-05	0.000132	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—CXCL8—psoriasis	1.17e-05	0.000132	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—CXCL8—psoriasis	1.17e-05	0.000132	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—CXCL8—psoriasis	1.16e-05	0.000131	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—CXCL8—psoriasis	1.15e-05	0.00013	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—APOE—psoriasis	1.14e-05	0.000129	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—LEP—psoriasis	1.14e-05	0.000129	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PPARG—psoriasis	1.13e-05	0.000128	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—APOE—psoriasis	1.12e-05	0.000127	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—APOE—psoriasis	1.12e-05	0.000126	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—LEP—psoriasis	1.12e-05	0.000126	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.11e-05	0.000125	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—APOE—psoriasis	1.09e-05	0.000124	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—LEP—psoriasis	1.09e-05	0.000124	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—LEP—psoriasis	1.09e-05	0.000123	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—APOE—psoriasis	1.09e-05	0.000123	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—CXCL8—psoriasis	1.08e-05	0.000122	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NFKBIA—psoriasis	1.07e-05	0.00012	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TYK2—psoriasis	1.06e-05	0.00012	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	1.06e-05	0.00012	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—CXCL8—psoriasis	1.06e-05	0.00012	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—CXCL8—psoriasis	1.06e-05	0.00012	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PPARG—psoriasis	1.06e-05	0.000119	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—CXCL8—psoriasis	1.05e-05	0.000119	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—CXCL8—psoriasis	1.04e-05	0.000118	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NFKBIA—psoriasis	1.04e-05	0.000118	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PPARG—psoriasis	1.04e-05	0.000118	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	1.02e-05	0.000115	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TYK2—psoriasis	1.02e-05	0.000115	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	1.01e-05	0.000115	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PPARG—psoriasis	9.77e-06	0.00011	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—APOE—psoriasis	9.65e-06	0.000109	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—LEP—psoriasis	9.61e-06	0.000109	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—APOE—psoriasis	9.61e-06	0.000109	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—APOE—psoriasis	9.46e-06	0.000107	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—LEP—psoriasis	9.46e-06	0.000107	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—APOE—psoriasis	9.45e-06	0.000107	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—APOE—psoriasis	9.44e-06	0.000107	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—LEP—psoriasis	9.44e-06	0.000107	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—APOE—psoriasis	9.41e-06	0.000106	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—LEP—psoriasis	9.41e-06	0.000106	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CAT—psoriasis	9.38e-06	0.000106	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—LEP—psoriasis	9.38e-06	0.000106	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—APOE—psoriasis	9.38e-06	0.000106	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—LEP—psoriasis	9.28e-06	0.000105	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—APOE—psoriasis	9.28e-06	0.000105	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CXCL8—psoriasis	9.27e-06	0.000105	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CARM1—psoriasis	9.17e-06	0.000104	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CAT—psoriasis	9.16e-06	0.000103	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NFKBIA—psoriasis	8.96e-06	0.000101	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CXCL8—psoriasis	8.88e-06	0.0001	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—IL6—psoriasis	8.81e-06	9.96e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	8.81e-06	9.95e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NFKBIA—psoriasis	8.79e-06	9.93e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NFKBIA—psoriasis	8.76e-06	9.9e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NFKBIA—psoriasis	8.74e-06	9.87e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TYK2—psoriasis	8.73e-06	9.87e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NFKBIA—psoriasis	8.65e-06	9.77e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CAT—psoriasis	8.63e-06	9.75e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—JUN—psoriasis	8.62e-06	9.74e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TYK2—psoriasis	8.54e-06	9.65e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—IL6—psoriasis	8.44e-06	9.54e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PPARG—psoriasis	8.4e-06	9.49e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TYK2—psoriasis	8.35e-06	9.44e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TYK2—psoriasis	8.31e-06	9.39e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—NFKB1—psoriasis	8.3e-06	9.37e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—JUN—psoriasis	8.25e-06	9.32e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PPARG—psoriasis	8.23e-06	9.3e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—NFKB1—psoriasis	7.94e-06	8.97e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CXCL8—psoriasis	7.6e-06	8.59e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—VEGFA—psoriasis	7.53e-06	8.51e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—STAT3—psoriasis	7.45e-06	8.42e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CXCL8—psoriasis	7.44e-06	8.4e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TYK2—psoriasis	7.33e-06	8.29e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CAT—psoriasis	7.31e-06	8.26e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—APOE—psoriasis	7.29e-06	8.23e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CXCL8—psoriasis	7.27e-06	8.22e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CXCL8—psoriasis	7.24e-06	8.17e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—IL6—psoriasis	7.23e-06	8.17e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TYK2—psoriasis	7.22e-06	8.15e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—VEGFA—psoriasis	7.21e-06	8.14e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TYK2—psoriasis	7.2e-06	8.14e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TYK2—psoriasis	7.18e-06	8.11e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TYK2—psoriasis	7.16e-06	8.08e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—STAT3—psoriasis	7.14e-06	8.06e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—APOE—psoriasis	7.11e-06	8.04e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TYK2—psoriasis	7.09e-06	8.01e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—IL6—psoriasis	7.07e-06	7.99e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—JUN—psoriasis	7.07e-06	7.99e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—IL6—psoriasis	6.92e-06	7.81e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—JUN—psoriasis	6.92e-06	7.81e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—IL6—psoriasis	6.88e-06	7.77e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NFKB1—psoriasis	6.81e-06	7.69e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—JUN—psoriasis	6.76e-06	7.64e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—JUN—psoriasis	6.73e-06	7.6e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—APOE—psoriasis	6.7e-06	7.57e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NFKB1—psoriasis	6.66e-06	7.52e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NFKB1—psoriasis	6.51e-06	7.35e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NFKB1—psoriasis	6.48e-06	7.32e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CXCL8—psoriasis	6.39e-06	7.21e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PPARG—psoriasis	6.35e-06	7.17e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CXCL8—psoriasis	6.28e-06	7.1e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CXCL8—psoriasis	6.27e-06	7.08e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CXCL8—psoriasis	6.25e-06	7.06e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CXCL8—psoriasis	6.23e-06	7.04e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PPARG—psoriasis	6.2e-06	7e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—VEGFA—psoriasis	6.18e-06	6.98e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CXCL8—psoriasis	6.17e-06	6.97e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—STAT3—psoriasis	6.12e-06	6.91e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—IL6—psoriasis	6.07e-06	6.86e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—VEGFA—psoriasis	6.04e-06	6.83e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—STAT3—psoriasis	5.98e-06	6.76e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL6—psoriasis	5.98e-06	6.75e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL6—psoriasis	5.96e-06	6.74e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL6—psoriasis	5.94e-06	6.71e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—JUN—psoriasis	5.94e-06	6.71e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL6—psoriasis	5.92e-06	6.69e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—psoriasis	5.91e-06	6.67e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—psoriasis	5.88e-06	6.64e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6—psoriasis	5.87e-06	6.63e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STAT3—psoriasis	5.85e-06	6.61e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—JUN—psoriasis	5.84e-06	6.6e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PPARG—psoriasis	5.84e-06	6.6e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—JUN—psoriasis	5.83e-06	6.59e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STAT3—psoriasis	5.82e-06	6.57e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—JUN—psoriasis	5.81e-06	6.56e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—JUN—psoriasis	5.79e-06	6.54e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—JUN—psoriasis	5.74e-06	6.48e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NFKB1—psoriasis	5.72e-06	6.46e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—psoriasis	5.69e-06	6.43e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—APOE—psoriasis	5.68e-06	6.42e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CAT—psoriasis	5.64e-06	6.37e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NFKB1—psoriasis	5.62e-06	6.35e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NFKB1—psoriasis	5.61e-06	6.34e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NFKB1—psoriasis	5.59e-06	6.32e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NFKB1—psoriasis	5.58e-06	6.3e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NFKB1—psoriasis	5.52e-06	6.24e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—psoriasis	5.45e-06	6.15e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6—psoriasis	5.21e-06	5.88e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—psoriasis	5.19e-06	5.86e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STAT3—psoriasis	5.14e-06	5.8e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—psoriasis	5.1e-06	5.77e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—psoriasis	5.09e-06	5.75e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—psoriasis	5.08e-06	5.73e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—psoriasis	5.06e-06	5.72e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STAT3—psoriasis	5.05e-06	5.71e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STAT3—psoriasis	5.04e-06	5.7e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STAT3—psoriasis	5.03e-06	5.68e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—psoriasis	5.01e-06	5.66e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STAT3—psoriasis	5.01e-06	5.66e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6—psoriasis	4.99e-06	5.63e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STAT3—psoriasis	4.96e-06	5.61e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PPARG—psoriasis	4.95e-06	5.59e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—psoriasis	4.67e-06	5.27e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—psoriasis	4.57e-06	5.16e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—psoriasis	4.46e-06	5.04e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—psoriasis	4.44e-06	5.02e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—APOE—psoriasis	4.38e-06	4.95e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6—psoriasis	4.27e-06	4.83e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6—psoriasis	4.18e-06	4.72e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6—psoriasis	4.09e-06	4.62e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6—psoriasis	4.06e-06	4.59e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—psoriasis	3.92e-06	4.43e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—psoriasis	3.86e-06	4.36e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—psoriasis	3.85e-06	4.35e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—psoriasis	3.84e-06	4.33e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—psoriasis	3.82e-06	4.32e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PPARG—psoriasis	3.82e-06	4.31e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—psoriasis	3.79e-06	4.28e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6—psoriasis	3.59e-06	4.05e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6—psoriasis	3.53e-06	3.99e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6—psoriasis	3.52e-06	3.98e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6—psoriasis	3.51e-06	3.97e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6—psoriasis	3.5e-06	3.95e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6—psoriasis	3.47e-06	3.92e-05	CbGpPWpGaD
